On December 6th, the National Office for the Management of High-Tech Enterprise Certification published an announcement regarding the record-filing of enterprises certified in 2024 by the Zhejiang provincial authority. Hangzhou Xunling Biotech Co., Ltd. was successfully included in this announcement, marking its certification as a National High-Tech Enterprise.
National High-Tech Enterprise refers to a company that operates within the "National Key Supported High-Tech Fields," continuously engages in R&D and the transformation of technological achievements, develops core proprietary intellectual property, and conducts business activities based on these assets. This certification authoritatively recognizes Xunling Biotech's strengths in technological innovation, transformation of scientific research outcomes, and independent intellectual property.
Building on this certification as a new starting point, Xunling Biotech will continue to uphold its corporate values of "Focus, Co-creation, and Altruism," adhere to innovation-driven development, and deepen its expertise in the animal healthcare diagnostics field. We will increase investment in technological R&D and product innovation, further promote the development and industrial application of animal medical testing technologies, and remain dedicated to providing customers with superior products and services while actively advancing the animal diagnostics industry.